Medexus Pharmaceuticals (MEDXF) Short Interest Ratio & Short Volume $2.11 +0.02 (+0.96%) As of 05/30/2025 02:31 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartShort InterestBuy This Stock Medexus Pharmaceuticals Short Interest DataMedexus Pharmaceuticals (MEDXF) has a short interest of 8,900 shares. This marks a 71.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 27,146 shares to cover all short positions.Current Short Interest8,900 sharesPrevious Short Interest5,200 sharesChange Vs. Previous Month+71.15%Dollar Volume Sold Short$17,132.50Short Interest Ratio0.5 Days to CoverLast Record DateMay 15, 2025Today's Trading Volume4,350 sharesAverage Trading Volume27,146 sharesToday's Volume Vs. Average16% Short Selling Medexus Pharmaceuticals? Sign up to receive the latest short interest report for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDXF Short Interest Over TimeMEDXF Days to Cover Over TimeMEDXF Percentage of Float Shorted Over Time Medexus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20258,900 shares $17,132.50 +71.2%N/A0.5 $1.93 4/30/20255,200 shares $10,296.00 -42.2%N/A0.1 $1.98 4/15/20259,000 shares $15,210.00 -58.9%N/A0.3 $1.69 3/31/202521,900 shares $36,354.00 -29.6%N/A0.8 $1.66 3/15/202531,100 shares $55,047.00 +18.7%N/A1.1 $1.77 2/28/202526,200 shares $51,076.90 +37.2%N/A0.5 $1.95 2/15/202519,100 shares $41,447.00 -89.4%N/A0.3 $2.17 1/31/2025180,500 shares $480,472.95 -32.6%N/A1.3 $2.66 1/15/2025267,900 shares $819,774.00 +76.1%N/A2.8 $3.06 12/31/2024152,100 shares $367,321.50 -3.9%N/A8.2 $2.42 Get the Latest News and Ratings for MEDXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/2024158,200 shares $321,304.20 -23.8%N/A7 $2.03 11/30/2024207,700 shares $396,707.00 +133.4%N/A13.9 $1.91 11/15/202489,000 shares $136,170.00 +16.6%N/A2.9 $1.53 10/31/202476,300 shares $130,015.20 -16.7%N/A11.9 $1.70 10/15/202491,600 shares $171,292.00 -20.4%N/A6.6 $1.87 9/30/2024115,000 shares $224,250.00 -14.8%N/A6.8 $1.95 9/15/2024134,900 shares $269,800.00 +4.3%N/A6.4 $2.00 8/31/2024129,400 shares $235,508.00 -12.1%N/A10.7 $1.82 8/15/2024147,200 shares $262,016.00 -7.6%N/A6.5 $1.78 7/31/2024159,300 shares $275,589.00 +10.1%N/A9.2 $1.73 7/15/2024144,700 shares $250,909.80 -8.2%N/A4 $1.73 6/30/2024157,600 shares $209,608.00 -3.0%N/A10 $1.33 6/15/2024162,500 shares $185,656.25 +0.8%N/A2.2 $1.14 5/31/2024161,200 shares $188,604.00 +6.5%N/A9.8 $1.17 5/15/2024151,400 shares $180,166.00 +26.9%N/A11.4 $1.19 4/30/2024119,300 shares $160,458.50 +15.2%N/A4.1 $1.35 4/15/2024103,600 shares $118,259.40 +30.5%N/A2.4 $1.14 3/31/202479,400 shares $96,788.60 +14.6%N/A3.1 $1.22 3/15/202469,300 shares $81,081.00 +56.8%N/A2.8 $1.17 2/29/202444,200 shares $58,286.54 +122.1%N/A2.1 $1.32 2/15/202419,900 shares $27,462.00 +192.7%N/A0.3 $1.38 1/15/20247,800 shares $15,522.00 +333.3%N/A0.2 $1.99 12/31/20231,800 shares $3,402.00 No ChangeN/A0.1 $1.89 11/30/20234,200 shares $4,552.80 +35.5%N/A0.4 $1.08 11/15/20233,100 shares $4,092.00 -67.4%N/A0.3 $1.32 10/31/20239,500 shares $13,965.00 -84.3%N/A0.9 $1.47 10/15/202360,300 shares $108,540.00 -92.6%N/A6.8 $1.80 9/30/2023814,300 shares $1.82 million -5.6%N/A63.6 $2.24 9/15/2023863,000 shares $2.06 million -6.7%N/A65.9 $2.39 8/31/2023925,000 shares $2.00 million +97.5%N/A24.8 $2.16Why July 22nd Could Mean Big Changes for Social Security (Ad)In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Social Security — and his plan is set to roll out July 22. What's coming next isn't about trimming waste.To see the full playbook and how it could impact everyone, click here. 8/15/2023468,300 shares $894,453.00 -1.2%N/A8.4 $1.91 7/31/2023474,200 shares $751,607.00 -0.3%N/A46.5 $1.59 7/15/2023475,600 shares $731,472.80 +16.2%N/A23 $1.54 6/30/2023409,300 shares $568,927.00 +0.4%N/A11.2 $1.39 6/15/2023407,600 shares $362,111.84 -0.6%N/A64.7 $0.89 5/31/2023410,000 shares $378,020.00 -0.1%N/A64.1 $0.92 5/15/2023410,200 shares $370,369.58 -1.3%N/A26 $0.90 4/30/2023415,500 shares $400,001.85 +1.8%N/A62 $0.96 4/15/2023408,200 shares $449,020.00 -1.0%N/A14 $1.10 3/31/2023412,200 shares $491,466.06 -0.9%N/A19.8 $1.19 3/15/2023415,800 shares $469,854.00 +2.0%N/A80 $1.13 2/28/2023407,600 shares $538,032.00 0.0%N/A10.1 $1.32 2/15/2023407,700 shares $387,315.00 +0.0%N/A14.2 $0.95 1/31/2023407,600 shares $574,716.00 -0.5%N/A10.3 $1.41 1/15/2023409,800 shares $649,533.00 +4.4%N/A9.9 $1.59 12/30/2022392,600 shares $604,604.00 -1.3%N/A14.5 $1.54 12/15/2022397,700 shares $562,586.42 +0.1%N/A12.5 $1.41 11/30/2022397,500 shares $680,758.50 +11.2%N/A19.1 $1.71 11/15/2022357,500 shares $493,350.00 +0.3%N/A9.3 $1.38 10/31/2022356,300 shares $381,241.00 +2.6%N/A15.6 $1.07 10/15/2022347,300 shares $309,097.00 +37.3%N/A7.1 $0.89 9/30/2022253,000 shares $179,655.30 +41.7%N/A2.3 $0.71 9/15/2022178,500 shares $255,255.00 -4.6%N/A12.4 $1.43 8/31/2022187,100 shares $357,361.00 +298.1%N/A8.5 $1.91 8/15/202247,000 shares $114,680.00 -23.1%N/A1.8 $2.44 7/31/202261,100 shares $109,980.00 -17.4%N/A5.4 $1.80 7/15/202274,000 shares $101,594.60 -15.7%N/A9.6 $1.37 6/30/202287,800 shares $135,212.00 -3.4%N/A9.4 $1.54 6/15/202290,900 shares $136,386.36 -16.6%N/A23.3 $1.50 5/31/2022109,000 shares $182,030.00 +6.2%N/A4.7 $1.67 5/15/2022102,600 shares $218,025.00 -2.1%N/A13.5 $2.13 4/30/2022104,800 shares $247,852.00 -0.9%N/A36.1 $2.37 4/15/2022105,700 shares $270,592.00 -2.3%N/A13.2 $2.56 3/31/2022108,200 shares $271,582.00 -8.0%N/A12 $2.51 3/15/2022117,600 shares $277,100.88 -11.0%N/A13.1 $2.36 2/28/2022132,100 shares $344,781.00 -3.4%N/A6.6 $2.61 2/15/2022136,700 shares $358,154.00 -7.5%N/A8.5 $2.62 1/31/2022147,700 shares $336,756.00 +0.5%N/A6.2 $2.28 1/15/2022147,000 shares $313,110.00 +6.6%N/A7.4 $2.13 12/31/2021137,900 shares $277,179.00 -4.2%N/A3.5 $2.01 12/15/2021143,900 shares $274,849.00 +38.6%N/A3.1 $1.91 11/30/2021103,800 shares $223,170.00 +84.0%N/A2.4 $2.15 11/15/202156,400 shares $133,386.00 +35.6%N/A1.5 $2.37 10/29/202141,600 shares $110,240.00 +112.2%N/A1.7 $2.65 10/15/202119,600 shares $55,693.40 +78.2%N/A0.7 $2.84 9/30/202111,000 shares $26,015.00 No ChangeN/A0.5 $2.37 8/31/20215,700 shares $18,810.00 +90.0%N/A0.1 $3.30 8/13/20213,000 shares $9,600.00 +500.0%N/A0 $3.20 7/30/2021500 shares $2,942.50 -54.6%N/A0 $5.89 7/15/20211,100 shares $6,644.00 +175.0%N/A0 $6.04Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 6/30/2021400 shares $2,368.00 -75.0%N/A0 $5.92 6/15/20211,600 shares $10,568.16 +100.0%N/A0 $6.61 5/28/2021800 shares $4,848.00 -11.1%N/A0 $6.06 5/14/2021900 shares $5,178.60 -52.6%N/A0 $5.75 4/30/20211,900 shares $11,685.00 +171.4%N/A0 $6.15 4/15/2021700 shares $4,102.70 -12.5%N/A0 $5.86 3/31/2021800 shares $5,058.56 -66.7%N/A0 $6.32 3/15/20212,400 shares $13,920.00 -96.8%N/A0 $5.80 2/26/202175,300 shares $463,848.00 -1.4%N/A1.5 $6.16 2/12/202176,400 shares $0.00 +159.9%N/A3 $0.00 1/29/202129,400 shares $0.00 +988.9%N/A0.5 $0.00 1/15/20216,300 shares $0.00 +530.0%N/A0.3 $0.00 12/31/20203,300 shares $0.00 -47.6%N/A0.3 $0.00 MEDXF Short Interest - Frequently Asked Questions What is Medexus Pharmaceuticals' current short interest? Short interest is the volume of Medexus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 8,900 shares of MEDXF short. Learn More on Medexus Pharmaceuticals' current short interest. Is Medexus Pharmaceuticals' short interest increasing or decreasing? Medexus Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 8,900 shares, an increase of 71.2% from the previous total of 5,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Medexus Pharmaceuticals stock? Short selling MEDXF is an investing strategy that aims to generate trading profit from Medexus Pharmaceuticals as its price is falling. MEDXF shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medexus Pharmaceuticals? A short squeeze for Medexus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDXF, which in turn drives the price of the stock up even further. How often is Medexus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDXF, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRHF Short Squeeze ACRDF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDXF) was last updated on 6/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDXF Stock Free MEDXF Stock Alerts